<DOC>
	<DOC>NCT02094586</DOC>
	<brief_summary>The primary goal of this Phase III study is to compare 3 lots for consistency of manufacture.</brief_summary>
	<brief_title>A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Cholera</mesh_term>
	<criteria>healthy men or women, age 18 to 45 years inclusive; normal medical history and physical examination Women must have a negative pregnancy test. travel to a cholera endemic area in the previous 5 years; abnormal stool pattern or regular use of laxatives; Currently active unstable or undiagnosed medical conditions current or recent antibiotic use; pregnancy or nursing; Previously received a licensed or investigational cholera vaccine History of cholera or enterotoxigenic E. coli infection History of GuillainBarr√© Syndrome Received or plans to receive any other licensed vaccines, except for seasonal influenza Recipient of bone marrow or solid organ transplant Malignancy (excluding nonmelanotic skin cancers) or lymphoproliferative disorders diagnosed or treated during the past 5 years Use of systemic chemotherapy in the previous 5 years prior to the study any immunosuppressive medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>